Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q2 2021 Results – Earnings Call Transcript

Akebia Therapeutics, Inc. (AKBA) Q2 2021 Results Conference Call August 5, 2021 9:00 AM ET
Company Participants
Kristen Sheppard – SVP, IR
John Butler – CEO
David Spellman – CFO
Dr. Steven Burke – Chief Medical Officer
Dell Faulkingham – Chief Commercial…

Click here to view the original article.